truFel Ultra C2

Feline Calicivirus Vaccine

Killed Virus

For use in animals only

This product has been shown to be effective for vaccination of healthy cats 8 weeks of age or older, against feline calicivirus. The duration of immunity for this product has not been determined. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

The vaccine contains one additional feline calicivirus strain isolated from one hemorrhagic calicivirus outbreak that occurred in 1998 and was shown to be effective for vaccination of cats against calicivirus-induced hemorrhagic disease in controlled vaccination challenge experiments.

Dose: Inject one 0.5 mL dose subcutaneously using aseptic technique. Healthy cats should receive two doses, 3 to 4 weeks apart, except that if the animal is less than 16 weeks of age, the final dose should be given no earlier than 16 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.

truFel Ultra C2 Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

truFel Ultra C2 Caution

Store in the dark at 2° to 8°C (35° to 46°F). AVOID FREEZING. SHAKE WELL. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. A small percentage of patients may experience transient lethargy, pyrexia and anorexia, and some cats may show transient discomfort (such as stinging, itching or pain) at the injection site. In exceptional circumstances, hypersensitivity or anaphylaxis may occur, requiring appropriate symptomatic treatment. In case of human exposure, contact a physician. Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.

Elanco US Inc., Fort Dodge, IA 50501

Phone: 888-545-5973

VLN/PCN 196/15C5.22

TruFel, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2021 Elanco or its affiliates.

25 Doses

25 x 0.5 mL Vials of Vaccine

YL102916A

CPN: 1943029.2